These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31865510)

  • 1. Prediction of lower-grade glioma molecular subtypes using deep learning.
    Matsui Y; Maruyama T; Nitta M; Saito T; Tsuzuki S; Tamura M; Kusuda K; Fukuya Y; Asano H; Kawamata T; Masamune K; Muragaki Y
    J Neurooncol; 2020 Jan; 146(2):321-327. PubMed ID: 31865510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in
    Batchala PP; Muttikkal TJE; Donahue JH; Patrie JT; Schiff D; Fadul CE; Mrachek EK; Lopes MB; Jain R; Patel SH
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):426-432. PubMed ID: 30705071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
    Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
    Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Subtype Classification in Lower-Grade Glioma with Accelerated DTI.
    Aliotta E; Nourzadeh H; Batchala PP; Schiff D; Lopes MB; Druzgal JT; Mukherjee S; Patel SH
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1458-1463. PubMed ID: 31413006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
    Chen SC; Lo CM; Wang SH; Su EC
    BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subtype classification of low-grade gliomas using magnetic resonance imaging-based radiomics and machine learning.
    Lam LHT; Do DT; Diep DTN; Nguyet DLN; Truong QD; Tri TT; Thanh HN; Le NQK
    NMR Biomed; 2022 Nov; 35(11):e4792. PubMed ID: 35767281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm.
    van der Voort SR; Incekara F; Wijnenga MMJ; Kapas G; Gardeniers M; Schouten JW; Starmans MPA; Nandoe Tewarie R; Lycklama GJ; French PJ; Dubbink HJ; van den Bent MJ; Vincent AJPE; Niessen WJ; Klein S; Smits M
    Clin Cancer Res; 2019 Dec; 25(24):7455-7462. PubMed ID: 31548344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep semi-supervised learning for brain tumor classification.
    Ge C; Gu IY; Jakola AS; Yang J
    BMC Med Imaging; 2020 Jul; 20(1):87. PubMed ID: 32727476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiogenomics of lower-grade gliomas: machine learning-based MRI texture analysis for predicting 1p/19q codeletion status.
    Kocak B; Durmaz ES; Ates E; Sel I; Turgut Gunes S; Kaya OK; Zeynalova A; Kilickesmez O
    Eur Radiol; 2020 Feb; 30(2):877-886. PubMed ID: 31691122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
    Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
    Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting 1p/19q co-deletion status from magnetic resonance imaging using deep learning in adult-type diffuse lower-grade gliomas: a discovery and validation study.
    Yan J; Zhang S; Sun Q; Wang W; Duan W; Wang L; Ding T; Pei D; Sun C; Wang W; Liu Z; Hong X; Wang X; Guo Y; Li W; Cheng J; Liu X; Li ZC; Zhang Z
    Lab Invest; 2022 Feb; 102(2):154-159. PubMed ID: 34782727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine Learning-Based Radiomics for Molecular Subtyping of Gliomas.
    Lu CF; Hsu FT; Hsieh KL; Kao YJ; Cheng SJ; Hsu JB; Tsai PH; Chen RJ; Huang CC; Yen Y; Chen CY
    Clin Cancer Res; 2018 Sep; 24(18):4429-4436. PubMed ID: 29789422
    [No Abstract]   [Full Text] [Related]  

  • 14. Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016.
    Kebir S; Weber M; Lazaridis L; Deuschl C; Schmidt T; Mönninghoff C; Keyvani K; Umutlu L; Pierscianek D; Forsting M; Sure U; Stuschke M; Kleinschnitz C; Scheffler B; Colletti PM; Rubello D; Rischpler C; Glas M
    Clin Nucl Med; 2019 Mar; 44(3):214-220. PubMed ID: 30516675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI and CT Identify Isocitrate Dehydrogenase
    Patel SH; Batchala PP; Mrachek EKS; Lopes MS; Schiff D; Fadul CE; Patrie JT; Jain R; Druzgal TJ; Williams ES
    Radiology; 2020 Jan; 294(1):160-167. PubMed ID: 31714193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
    J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas.
    Yamauchi T; Ohno M; Matsushita Y; Takahashi M; Miyakita Y; Kitagawa Y; Kondo E; Tsushita N; Satomi K; Yoshida A; Ichimura K; Narita Y
    Brain Tumor Pathol; 2018 Jul; 35(3):148-158. PubMed ID: 29922974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI radiomics analysis of molecular alterations in low-grade gliomas.
    Shofty B; Artzi M; Ben Bashat D; Liberman G; Haim O; Kashanian A; Bokstein F; Blumenthal DT; Ram Z; Shahar T
    Int J Comput Assist Radiol Surg; 2018 Apr; 13(4):563-571. PubMed ID: 29270916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
    Aoki K; Nakamura H; Suzuki H; Matsuo K; Kataoka K; Shimamura T; Motomura K; Ohka F; Shiina S; Yamamoto T; Nagata Y; Yoshizato T; Mizoguchi M; Abe T; Momii Y; Muragaki Y; Watanabe R; Ito I; Sanada M; Yajima H; Morita N; Takeuchi I; Miyano S; Wakabayashi T; Ogawa S; Natsume A
    Neuro Oncol; 2018 Jan; 20(1):66-77. PubMed ID: 29016839
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.